COVID-19: Toxicities of Potential Therapies

May 13, 2020 • 00:21:18
COVID-19: Toxicities of Potential Therapies
Critical Care Perspectives in Emergency Medicine
COVID-19: Toxicities of Potential Therapies

May 13 2020 | 00:21:18

/

Show Notes

Currently, there is no approved treatment or proven therapy for COVID-19. As such, many have turned to treatments with little to no supporting evidence. In this podcast, we bring back EM Pharmacy extraordinaire Bryan Hayes to discuss information on the toxicities of potential therapies used in the management of patients with COVID-19.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

August 12, 2019 • 00:28:42
Episode Cover

Resuscitating The Critically Ill Geriatric Patient

The World’s population is aging. By 2030, 20 percent of the US population will be over the age of 65 years.  Older patients have...

Listen

Episode 0

June 10, 2021 • 00:34:56
Episode Cover

Mechanical Ventilation in the Patient with ARDS

More than 3 million patients develop ARDS each year across the globe.  Like any therapy, mechanical ventilation can induce further lung injury and cause...

Listen

Episode 0

September 17, 2019 • 00:19:53
Episode Cover

Do ED-Based ICUs Make a Difference?

Over the past decade, the annual hours of critical care delivered in US emergency departments has sharply risen. Undoubtedly, many critically ill patients remain...

Listen